Skip to main content
. 2022 Nov 29;14(23):5881. doi: 10.3390/cancers14235881

Scheme 1.

Scheme 1

Current recommendations on risk stratification ESGO/ESTRO/ESP 2020 and therapy based on classical risk factors.